In the Q-symbio study, only Myoqinon from Pharma Nord was used. This Q10 has the trade name Bio-Quinone. It is an oxidized Q10 dissolved in vegetable oil, and it is the original, documented form of Q10, which for many years has proven its worth in many scientific studies. It is an active form of Q10 with a high absorption, and it should not be confused with the newer reduced form of Q10 called ubiquinol or just QH.
The patients in the Q-symbio study who received the active treatment were each given Myoqinon (Bio-Quinone Q10), 100 mg 3 times a day. There was a reason why the participants did not get 300 mg once daily although this would have been easier. The reason is that, if you take more than 1 capsule daily, the absorption will be higher if you will spread the dosage out through the course of the day – e.g. 1 capsule at breakfast, 1 capsule at lunch time, and 1 capsule at dinner time - rather than taking the entire daily dose all at once.